Her experience spans API manufacturing, combination products, and pharmaceutical development from Phase I through commercialization, enabling her to anticipate risk, guide best practices, and keep programs on track, even as priorities evolve.
Vicki joined Pace® in 2024 through the acquisition of Catalent’s Small Molecule Center of Excellence and her tenure with the site dates to 2017.
Vicki holds a master’s degree in chemistry from the University of South Florida.
Get in touch
Whether you’re shaping early plans or preparing to scale, our teams are here to help you move forward with clarity and confidence. Start the conversation and we’ll get back to you quickly.